There is growing evidence that Pfizer was well aware that its COVID-19 vaccines were risky when they pushed them on the world and brought in record profits.
One document that has been getting a lot of attention on social media is the drug maker’s “Cumulative Analysis of Post-Authorization Adverse Event Reports of PF-07302048 (BNT162B2) Received Through 28-Feb-2021”, with the numbers referring to the Pfizer-BioNTech COVID-19 vaccine. It contains cumulative post-authorization safety data. The document notes that Pfizer’s safety database records adverse events that are reported to the manufacturer, published in medical literature, and reported by health authorities, among other sources.
It contains a chart showing some of the most commonly reported adverse events following vaccination, and the top classifications were general disorders, nervous system, musculoskeletal, gastrointestinal and skin related, although cardiac, vascular, psychiatric and many other categories also appeared. When it came to events reported in more than 2% of cases, tachycardia, myalgia, nausea, fatigue and numerous others were listed.
There was also a shockingly long list of adverse events of special interest (AESI), which are medical concerns specific to a vaccine or medication that require close monitoring during and after clinical trials. Rather than serving as an official list of side effects, its purpose is safety surveillance, but the fact that there are so many of them should give everyone serious pause.
The appendix contains a full NINE pages of adverse events of special interest. It is so lengthy that it might have been easier for them to list the side effects they weren’t concerned about monitoring. […]
— Read More: www.naturalnews.com
What Would You Do If Pharmacies Couldn’t Provide You With Crucial Medications or Antibiotics?
The medication supply chain from China and India is more fragile than ever since Covid. The US is not equipped to handle our pharmaceutical needs. We’ve already seen shortages with antibiotics and other medications in recent months and pharmaceutical challenges are becoming more frequent today.
Our partners at Jase Medical offer a simple solution for Americans to be prepared in case things go south. Their “Jase Case” gives Americans emergency antibiotics they can store away while their “Jase Daily” offers a wide array of prescription drugs to treat the ailments most common to Americans.
They do this through a process that embraces medical freedom. Their secure online form allows board-certified physicians to prescribe the needed drugs. They are then delivered directly to the customer from their pharmacy network. The physicians are available to answer treatment related questions.
